Johnson//Becker, PLLC is a nationwide product liability law firm with extensive experience representing clients affected by dangerous or defective pharmaceuticals.
On June 2, 2023, the Judicial Panel on MultiDistrict Litigation consolidated several Tepezza hearing loss lawsuits into a multidistrict litigation (MDL) in Illinois. The Tepezza MDL will be overseen by U.S. District Judge Thomas M. Durkin. The Defendant in the lawsuits is Horizon Therapeutics USA, headquartered in Illinois.
The litigation is currently comprised of approximately 37 cases. The lawsuits allege that Tepezza caused the users to develop hearing loss and tinnitus and that the company failed to provide an adequate warning of the risks of the drug.
Intended to treat thyroid eye disease or bulging eyes, Tepezza is a new-generation biologic treatment introduced by Horizon Therapeutics in January 2020. Since then, numerous case reports were published in the medical literature reporting links between the drug and patients experiencing hearing loss and tinnitus.
After oral arguments were made in May 2023, the U.S. Judicial Panel on Multidistrict Litigation issued the transfer order on June 2, officially consolidating the Tepezza lawsuits in Illinois.
Johnson//Becker filed the first known Tepezza lawsuit in the U.S. Additionally, the Johnson//Becker lawyers currently represent a number of clients suffering from hearing loss side effects after using Tepezza.
Questions About a Tepezza Lawsuit? Contact a Johnson//Becker Tepezza Lawyer for a Free Case Review.
If you or a loved one took Tepezza and were diagnosed with hearing loss, you may want to speak with the Tepezza lawyers at Johnson//Becker. We are currently accepting new Tepezza lawsuits across the country, and you may be entitled to financial compensation.
We offer a Free Case Evaluation. Please contact us using the form below or by calling us at (800) 279-6386.
We would be honored to speak with you and respond promptly to every inquiry we receive.